Phase 2 Readout
MIRM: Phase 2 Readout: volixibat
March 31, 2027 · volixibat. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- March 31, 2027
- Company
- Mirum Pharmaceuticals, Inc. (MIRM)
- Drug
- volixibat
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: volixibat
- Drug
- volixibat
- Indication
- primary biliary cholangitis ("PBC")